(Q37261484)

19 August 2017

Evaluation of effect of acarbose consumption on weight losing in non-diabetic overweight or obese patients in Kerman (English)

1 reference

19 August 2017

0 references

Akram Nakhaee

1

1 reference

19 August 2017

Mojgan Sanjari

series ordinal

2

1 reference

19 August 2017

1 May 2013

1 reference

Journal of Research in Medical Sciences

19 August 2017

1 reference

19 August 2017

18

1 reference

19 August 2017

5

1 reference

19 August 2017

391-394

1 reference

Association of physical activity and dietary behaviours in relation to the body mass index in a national sample of Iranian children and adolescents: CASPIAN Study

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3810572

Is there a role for metformin or acarbose as a weight-loss agent in the absence of diabetes?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3810572

Prevalence of metabolic syndrome by the Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions and their association with coronary heart disease in an elderly Iranian population

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3810572

Combined treatment with exercise training and acarbose improves metabolic control and cardiovascular risk factor profile in subjects with mild type 2 diabetes.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3810572

The effect of acarbose on insulin resistance in obese hypertensive subjects with normal glucose tolerance: a randomized controlled study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3810572

Efficacy of acarbose in Chinese subjects with impaired glucose tolerance

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3810572

Efficacy and tolerability of acarbose in Asian patients with type 2 diabetes inadequately controlled with diet and sulfonylureas

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3810572

Latin-American trial of orlistat for weight loss and improvement in glycaemic profile in obese diabetic patients

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3810572

Effect of acarbose on weight maintenance after dietary weight loss in obese subjects

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3810572

Acarbose treatment in obesity: a controlled study

3 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24174943

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Small weight loss on long-term acarbose therapy with no change in dietary pattern or nutrient intake of individuals with non-insulin-dependent diabetes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24174943

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

1 reference

19 August 2017

PubMed publication ID

24174943

1 reference